These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35237126)

  • 1. Editorial: Brain Cancers: New Perspectives and Therapies.
    Roda E; Bottone MG
    Front Neurosci; 2022; 16():857408. PubMed ID: 35237126
    [No Abstract]   [Full Text] [Related]  

  • 2. A Critical Overview of Targeted Therapies for Glioblastoma.
    Jain KK
    Front Oncol; 2018; 8():419. PubMed ID: 30374421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives.
    Raucher D; Dragojevic S; Ryu J
    Front Oncol; 2018; 8():624. PubMed ID: 30619758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain tumor stem cells: Molecular characteristics and their impact on therapy.
    Schonberg DL; Lubelski D; Miller TE; Rich JN
    Mol Aspects Med; 2014 Oct; 39():82-101. PubMed ID: 23831316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cells for the treatment of glioblastoma: a 20-year perspective.
    Calinescu AA; Kauss MC; Sultan Z; Al-Holou WN; O'Shea SK
    CNS Oncol; 2021 Jun; 10(2):CNS73. PubMed ID: 34006134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of targeting glucose metabolism in glioma stem cells.
    Nakano I
    Expert Opin Ther Targets; 2014 Nov; 18(11):1233-6. PubMed ID: 25077882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell-based therapies for tumors in the brain: are we there yet?
    Shah K
    Neuro Oncol; 2016 Aug; 18(8):1066-78. PubMed ID: 27282399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-Targeted Glial Brain Tumor Therapies.
    Sharma P; Debinski W
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30366424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the perivascular niche in brain tumors.
    Seano G
    Curr Opin Oncol; 2018 Jan; 30(1):54-60. PubMed ID: 29135607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Targeted therapy in glioblastoma: update and perspectives].
    Idbaih A; Duran-Peña A; Alentorn A
    Bull Acad Natl Med; 2015 Nov; 199(8-9):1323-1329. PubMed ID: 29874421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
    Kim SS; Harford JB; Pirollo KF; Chang EH
    Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.
    Mattei V; Santilli F; Martellucci S; Delle Monache S; Fabrizi J; Colapietro A; Angelucci A; Festuccia C
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide and other potential agents for the treatment of glioblastoma multiforme.
    Nagasawa DT; Chow F; Yew A; Kim W; Cremer N; Yang I
    Neurosurg Clin N Am; 2012 Apr; 23(2):307-22, ix. PubMed ID: 22440874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives.
    Seker-Polat F; Pinarbasi Degirmenci N; Solaroglu I; Bagci-Onder T
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives.
    Weenink B; French PJ; Sillevis Smitt PAE; Debets R; Geurts M
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32235752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma multiforme: overview of current treatment and future perspectives.
    Anton K; Baehring JM; Mayer T
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):825-53. PubMed ID: 22794286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma.
    Reichel D; Sagong B; Teh J; Zhang Y; Wagner S; Wang H; Chung LWK; Butte P; Black KL; Yu JS; Perez JM
    ACS Nano; 2020 Jul; 14(7):8392-8408. PubMed ID: 32551496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting glioblastoma-derived pericytes improves chemotherapeutic outcome.
    Guerra DAP; Paiva AE; Sena IFG; Azevedo PO; Silva WN; Mintz A; Birbrair A
    Angiogenesis; 2018 Nov; 21(4):667-675. PubMed ID: 29761249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma: Pathogenesis and Current Status of Chemotherapy and Other Novel Treatments.
    Rajaratnam V; Islam MM; Yang M; Slaby R; Ramirez HM; Mirza SP
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zika virus infection induces MiR34c expression in glioblastoma stem cells: new perspectives for brain tumor treatments.
    Iannolo G; Sciuto MR; Cuscino N; Pallini R; Douradinha B; Ricci Vitiani L; De Maria R; Conaldi PG
    Cell Death Dis; 2019 Mar; 10(4):263. PubMed ID: 30890698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.